Prevalence of depression morbidity among Brazilian adults: a systematic review and meta-analysis

Abstract

Objective: To estimate the prevalence of depressive symptoms and major depressive disorder, as assessed in population-based cross-sectional studies of Brazilian adults. Methods: We performed a systematic review of the literature. The major databases were searched up through October 2013. Two researchers selected the studies, extracted the data, and assessed their methodological quality. Meta-analyses were performed using random effects. Results: Of the 2,971 records retrieved, we selected 27 studies that assessed the prevalence of depression morbidity in 464,734 individuals (66% women). Eleven different screening tools were used to assess depression morbidity. The prevalence of depressive symptoms was 14% (95% confidence interval [95%CI] 13-16; I 2 = 99.5%), whereas the 1-year prevalence of major depressive disorder was 8% (95%CI 7-10; I 2 = 86.7%), and the lifetime prevalence of major depressive disorder was 17% (95%CI 14-19; I 2 = 91.6%). All rates were higher in women than in men. No causes of heterogeneity could be identified. Conclusion: Depression morbidity was common among Brazilian adults, and affects more women than men. Inconsistencies across studies highlight the need for standardization of future research. Clinicians should routinely investigate for the presence of depression morbidity in this population.

Adiponectin and depression: A meta-analysis

“…Depression is a state of low mood and the avoidance of activity that affects a sense of well-being, thoughts, behavior and feelings (1). Depression can result in numerous feelings, including anxiety, sadness, worry, helplessness and worthlessness.…”

Suicide risk and prevalence of major depressive disorder (MDD) among individuals infected with HIV-1 subtype C versus B in Southern Brazil

“…In Brazil, the annual prevalence of depression in the general population is considered to be between 3% and 11% (Jenkins et al, 1997; Kessler et al, 1994), and about 10% among patients in primary health care (Ustun and Sartorius, 1995). In a systematic review and meta-analysis of the prevalence of depression morbidity among Brazilian adults, the prevalence of depressive symptoms was 14% and the lifetime prevalence of MDD was 17% (Silva et al, 2014). …”

Uso De Antidepressivos Em Um Município Do Rio Grande Do Sul

“…Considerando a frequência elevada a WHO projeta que a depressão será o segundo maior problema de saúde pú-blica em 2020 (WHO, 2014 Silva et al (2014) a prevalência de sintomas depressivos na população pesquisada nos estudos foi de 14% (mínimo de 13 e máximo de 16, Intervalo de Confiança 95%) e segundo Berghöfer et al (2011) a depressão é um dos principais motivos de consulta médica nos serviços de Atenção Primária à Saúde (APS), sendo o transtorno mental mais prevalente.…”